Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael White

Showing results (111-120 of 585) with videos related to

Pageof 59
Sort By:
Pharmacotherapy|June 30, 2004
Anemia management in heart failure: a thick review of thin dataBrian F McBride, C Michael White
The Annals of Pharmacotherapy|June 3, 2025
Believing FDA's Assurance of Quality Pharmaceutical Products Can Be Dangerous to Your Patients' HealthC Michael White, Lyla R White
Nature|December 6, 2013
Coastal regionsJuliane Mossinger, Michael White, Patrick Goymer
The Annals of Pharmacotherapy|February 21, 2024
Eye Drop Quality Issues: Can the FDA See This One Through?Lyla R White, C Michael White
Pharmacotherapy|August 19, 2003
Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic managementBrian F McBride, C Michael White
The Annals of Pharmacotherapy|March 21, 2018
The Emerging Role of Inflammation in Cardiovascular DiseaseBrandon K Martinez, C Michael White
Journal of Clinical Pharmacology|December 17, 2004
Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMETBrian F McBride, C Michael White
Journal of Clinical Pharmacology|December 2, 2021
Response to Letter to the Editor by Dr RobinsonC Michael White, Lyla R White
Journal of Clinical Pharmacology|March 13, 2022
Inclisiran: A Novel Small Interfering RNA Drug for Low-Density Lipoprotein ReductionKimberly W Smith, C Michael White
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 7, 2009
Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromesWilliam L Baker, C Michael White
Pageof 59

Showing results (111-120 of 585) with videos related to

Sort By:
Pageof 59
Pharmacotherapy|June 30, 2004
Anemia management in heart failure: a thick review of thin dataBrian F McBride, C Michael White
The Annals of Pharmacotherapy|June 3, 2025
Believing FDA's Assurance of Quality Pharmaceutical Products Can Be Dangerous to Your Patients' HealthC Michael White, Lyla R White
Nature|December 6, 2013
Coastal regionsJuliane Mossinger, Michael White, Patrick Goymer
The Annals of Pharmacotherapy|February 21, 2024
Eye Drop Quality Issues: Can the FDA See This One Through?Lyla R White, C Michael White
Pharmacotherapy|August 19, 2003
Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic managementBrian F McBride, C Michael White
The Annals of Pharmacotherapy|March 21, 2018
The Emerging Role of Inflammation in Cardiovascular DiseaseBrandon K Martinez, C Michael White
Journal of Clinical Pharmacology|December 17, 2004
Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMETBrian F McBride, C Michael White
Journal of Clinical Pharmacology|December 2, 2021
Response to Letter to the Editor by Dr RobinsonC Michael White, Lyla R White
Journal of Clinical Pharmacology|March 13, 2022
Inclisiran: A Novel Small Interfering RNA Drug for Low-Density Lipoprotein ReductionKimberly W Smith, C Michael White
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 7, 2009
Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromesWilliam L Baker, C Michael White
Pageof 59